Vhb Pharmaceuticals Private Limited, a active private limited company, was established on 10 November 1995 in Kandivlai West, Maharashtra, India. Engaging in drug formulation & development within the pharma sector, it holds CIN: U24231MH1995PTC094365. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Uttamchand Kesharimal Jain (Director), Ashokkumar Keshrimal Jain (Director), Pravin Keshrimal Jain (Director). Past directors included Vipulkumar Rameshchandra Bhagat, Uttamchand Kesharimal Jain, Ashokkumar Keshrimal Jain. Its latest AGM occurred on 25 September 2025, with the balance sheet filed on 31 March 2025. It is based at 30 A, Government Industrial Estate,, Charkop, Kandivali (West), Mumbai, Maharashtra, India, Pin 400067, Kandivlai West, Maharashtra, 400067.
U24231MH1995PTC094365
094365
10 November 1995
₹0.50 M
₹0.40 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Vhb Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Uttamchand Kesharimal Jain | Director | 27 Sep 2012 | Current |
| Ashokkumar Keshrimal Jain | Director | 27 Sep 2012 | Current |
| Pravin Keshrimal Jain | Director | 27 Sep 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 18 Dec 2012 | Past |
| Pramod Abcsdd | Additional Director | 18 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 18 Sep 2013 | Past |
| Pramod Abcsdd | Additional Director | 18 Sep 2013 | Past |
| Pramod Abcsdd | Director | 18 Dec 2012 | Past |
| Pramod Abcsdd | Director | 16 Mar 2009 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Vhb Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 275.42% decrease in profit. The company's net worth dipped by a decrease of 6.9%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
In 2023, Vhb Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Vhb Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Vhb Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vhb Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Vhb Pharmaceuticals Private Limited last Annual general meeting of members was held on 25 Sep 2025 as per latest MCA records. was completed.
The activity Vhb Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was completed.
Uttamchand Kesharimal Jain was appointed as a Director was appointed as a Director on 27 Sep 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
Progress on Ashokkumar Keshrimal Jain was appointed as a Director was appointed as a Director on 27 Sep 2012 & has been associated with this company since 13 years 3 months . was documented.
Pravin Keshrimal Jain was appointed as a Director was appointed as a Director on 27 Sep 2012 & has been associated with this company since 13 years 3 months . was recorded as a recent event.
Vhb Pharmaceuticals Private Limited was registered on 10 Nov 1995 with Roc Mumbai & aged 30 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Vhb Pharmaceuticals Private Limited is U24231MH1995PTC094365.
Vhb Pharmaceuticals Private Limited is headquartered at 30 A, Government Industrial Estate,, Charkop, Kandivali (West), Mumbai, Maharashtra, India, Pin 400067, Kandivlai West, Maharashtra, 400067.
Vhb Pharmaceuticals Private Limited was incorporated on 10 November 1995.
The current directors of Vhb Pharmaceuticals Private Limited are
The primary industry of Vhb Pharmaceuticals Private Limited is Pharma.
Vhb Pharmaceuticals Private Limited is unlisted.
The authorized capital of Vhb Pharmaceuticals Private Limited is ₹0.50 M, and the paid-up capital is ₹0.40 M.
The compliance status of Vhb Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX